IP Library Granted Patent US 10,370,686
Granted Patent B2
US 10,370,686 · App. 15/005,719 · Granted Aug 6, 2019

Yeast cell modified to overproduce fatty acid and fatty acid-derived compounds

Inventors: Weerawat Runguphan (Mueang, TH); Jay D. Keasling (Berkeley, CA)
Assignee: The Regents of the University of California
C12P7/6409C12N9/1029C12N9/93C12N15/81C12P7/04C12P7/649C12P7/6463C12Y203/01085C12Y604/01002Y02E50/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,370,686
App. No.
15/005,719
Granted
Aug 6, 2019
Kind
B2
Abstract

The present invention provides for a genetically modified yeast host cell capable of producing one or more fatty acids, or fatty acid-derived compounds, or a mixture thereof, comprising: (a) increased expression of acetyl-CoA carboxylase (such as ACC1), (b) increased expression of one or more fatty acid synthases (such as FAS1 and FAS2), and (c) optionally reduced expression of one or more enzymes involved in or in the β-oxidation pathway (such as peroxisomal transporters PXA1 and PXA2, and β-oxidation enzymes POX1, POX2, and POX3).

Claims (24)

1. A genetically modified Saccharomyces cerevisiae host cell capable of producing one or more fatty acids, or fatty acid-derived compounds, or a mixture thereof, comprising:

(a) increased expression of acetyl-CoA carboxylase, wherein the endogenous promoter of the ACC1 gene is replaced with promoter P TEF1 ;

(b) increased expression of one or more fatty acid synthases, wherein the endogenous promoter of the FAS1 and FAS2 genes are replaced with promoter P TEF1 ;

(c) optionally reduced expression of one or more enzymes in the β-oxidation pathway, wherein the endogenous POX1 and/or PXA2 genes are deleted;

(d) a plasmid encoding an Escherichia coli TesA, which lacks a membrane signal peptide at a N-terminal end of TesA, operatively linked to promoter P GAL10 ; and

(e) reduced expression of fatty-acyl-CoA synthetases, wherein the endogenous FAA1 and/or FAA4 genes are deleted;

wherein the host cell does not comprise the ΔSnf2 mutation and the host cell is capable of producing at least 162 mg of free fatty acids when cultured in one liter of culture medium.

2. The host cell of claim 1 , wherein the one or more enzymes involved in or in the β-oxidation pathway are peroxisomal transporters PXA1 and PXA2, and β-oxidation enzymes PDX1, PDX2, and PDX3.

3. The host cell of claim 1 , wherein the fatty acid-derived compound is a fatty acyl ethyl ester (FAEE), a fatty alcohol, a triacylglycerol (TAG), or a mixture thereof.

4. The host cell of claim 1 , wherein the fatty acid is a C12:0, C14:0, C16:0, C16:1, C18:0, or C18:1, or mixture thereof, and the fatty acid-derived compound is a fatty acid methyl and ethyl esters (FAEE), fatty alcohol, or triacylglycerol (TAG) derived from one or more the following fatty acids: C12:0, C14:0, C16:0, C16:1, C18:0, and C18:1.

5. The host cell of claim 1 , wherein the host cell is capable of producing at least 201 mg of free fatty acids when cultured in one liter of culture medium.

6. The host cell of claim 5 , wherein the host cell is capable of producing at least 400 mg of free fatty acids when cultured in one liter of culture medium.

7. The host cell of claim 1 , wherein the host cell comprises the following genotype: Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0.

8. A method of constructing a genetically modified Saccharomyces cerevisiae host cell of the claimed invention, comprising:

(a) replacing the endogenous promoter of the ACC1 gene with promoter P TEF1 and the endogenous promoter of the FAS1 and FAS2 genes with promoter P TEF1 ;

(b) optionally the deleting the endogenous POX1 and/or PXA2 genes;

(c) introducing a plasmid encoding an Escherichia coli TesA, which lacks a membrane signal peptide at a N-terminal end of TesA, operatively linked to promoter P GAL10 into the host cell;

(d) deleting the endogenous FAA1 and/or FAA4 genes; and

(e) culturing the host cell in a cell culture such that the cell culture produces at least 162 mg of free fatty acids per one liter of culture medium;

wherein the host cell does not comprise the ΔSnf2 mutation.

9. The method of claim 8 , wherein the host cell comprises the following genotype: Matα; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0.

10. A method of producing one or more fatty acids, or fatty acid-derived compounds, or a mixture thereof, in a genetically modified yeast host cell of claim 1 , comprising culturing the genetically modified yeast host cell of claim 1 under a suitable condition such that the culturing results in the genetically modified yeast host cell producing the one or more fatty acids, or fatty acid-derived compounds, or a mixture thereof.

11. The method of claim 10 , further comprising:

recovering the one or more fatty acids, or fatty acid-derived compounds, or a mixture thereof, and optionally chemically treating the recovered compound to produce a second compound, wherein the second compound when combusted, can produce more energy that the combustion of the recovered compound.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 6, 2016
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 038364/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2016
From: RUNGUPHAN, WEERAWAT; KEASLING, JAY D.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 037636/0667 →
Continuity (3)
Continuation PCTUS2014048293 · Jul 25, 2014
Provisional Application 61858577 · Jul 25, 2013
Related Publication 20160215308A1 · Jul 28, 2016
Cited By (1)
US 12,188,073